References
- Guidelines for the prevention and treatment of hypertension China revision committee. Guidelines for the prevention and treatment of hypertension Chinese 2010. Chin J Cardiovasc Dis 2011;39:579-81
- Bang LM, Chapman TM, Goa KL. Lercanidipine: a review of its efficacy in the management of hypertension. Drugs 2003;63:2449-72
- Chobanian AV, Bakris GL, Blaek HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (The JNC 7 Report). J Am Med Assoc 2003;289:2560-72
- McInnes GT. Antihypertensive drugs in combination: additive or greater than additive? J Hum Hypertens 2007;21:914-16
- Egan BM. Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker. J Clin Hypertens (Greenwich) 2007;9:783-9
- National Institute for Health and Clinical Excellence. Hypertension (CG127): clinical management of primary hypertension in adults. http://www.nice.org.uk/guidance/CG127. Last accessed 3rd November 2014
- Burnier M. Renal protection with calcium antagonists: the role of lercanidipine. Curr Med Res Opin 2013;29:1727-35
- Sun RX. The 18th American Society of Hypertension: lercanidipine special report. Foreign Med Sci (section of Cardiovasc Dis) 2003;30:260-1